Nuvectis Pharma Inc. (NVCT)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
5.48
-0.16 (-2.84%)
At close: Jan 15, 2025, 2:54 PM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 |
Revenue | n/a | 149.00K | n/a | n/a |
Cost of Revenue | 22.90M | 19.23M | 12.89M | n/a |
Gross Profit | -22.90M | -19.09M | -12.89M | n/a |
Operating Income | -22.90M | -19.23M | -12.89M | -10.00K |
Interest Income | 637.00K | 149.00K | 4.00K | n/a |
Pretax Income | -22.26M | -19.09M | -12.89M | -10.00K |
Net Income | -22.26M | -18.79M | -12.89M | -10.00K |
Selling & General & Admin | 7.52M | 6.01M | 3.35M | 10.00K |
Research & Development | 15.38M | 13.23M | 9.54M | n/a |
Other Expenses | n/a | n/a | n/a | n/a |
Operating Expenses | 22.90M | 19.23M | 12.89M | 10.00K |
Interest Expense | n/a | 149.00K | n/a | n/a |
Selling & Marketing Expenses | 14.00K | n/a | n/a | 9.98K |
Cost & Expenses | 22.90M | 19.23M | 12.89M | 10.00K |
Income Tax | n/a | -298.00K | -4.00K | -24 |
Shares Outstanding (Basic) | 15.56M | 12.66M | 12.72M | 12.72M |
Shares Outstanding (Diluted) | 15.56M | 12.66M | 12.72M | 12.72M |
EPS (Basic) | -1.43 | -1.48 | -1.01 | -0.00 |
EPS (Diluted) | -1.43 | -1.48 | -1.01 | -0.00 |
EBITDA | -22.90M | -19.23M | -12.89M | n/a |
Depreciation & Amortization | -1.00M | -1.20M | -7.10M | 24.00K |